Illumina Inc (NAS:ILMN)
$ 151.5 0.41 (0.27%) Market Cap: 24.03 Bil Enterprise Value: 25.76 Bil PE Ratio: 0 PB Ratio: 11.26 GF Score: 80/100

Illumina Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript

Aug 12, 2020 / 05:00PM GMT
Release Date Price: $334.51 (+0.86%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Welcome to the day 2 of the conference.

Sorry for the lack of video. There was a power outage with our supplier. Hopefully, we'll get it rectified here shortly. So unfortunately, we're going to have audio only. But certainly, I don't think it will lack any of the content that will be coming through. Really pleased to be joined by Francis deSouza, President and CEO, obviously, of Illumina. Illumina has been the key anchor tenant here since the conference was started, I don't know, 6 or 7 years ago.

So Francis, we certainly appreciate your being with us today and giving us your time.

Francis A. deSouza
Illumina, Inc. - CEO, President & Director

Thank you, Dan, for having me.

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Terrific. I think you may wanted to read the safe harbor statement before we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot